Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Kappa Opioid Receptor Structure Revealed, A Potential Milestone in Medication Development – Maine Suboxone Treatment
Molecular mechanism of biased signaling at the kappa opioid receptor | Nature Communications
Structure of the human κ-opioid receptor in complex with JDTic | Nature
The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Opioid receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
Opioids in cancer: The κ‑opioid receptor (Review)
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
κ-opioid receptor - Wikipedia
Kappa Receptors – Opioid Peptides
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar
Activation of kappa opioid receptor (KOR) signaling increases... | Download Scientific Diagram
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kappa Opioid Receptor Internalization Assay - Innoprot GPCR Assays
κ-Opioid Receptor (KOP) | 7TM Antibodies
Kappa opioid receptor labeled with Tb (HTRF transiently expressing cells)
Opioid Receptor | kappa, mu Opioid Receptor
Top: Distribution of kappa opioid (7-transmembrane receptor), estrogen,... | Download Scientific Diagram
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
Scientists Take a Big Step toward Building a Better Opioid | Newsroom
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
